Earnings Call · Q1 FY2022·2022-05-12

Q1 22EPS -16.57%·Rev n/aQ4 21EPS -32.35%·Rev n/aQ3 21EPS -7.04%·Rev n/aQ2 21EPS -0.54%·Rev n/a⚠ consensus missing

X4 Pharmaceuticals, Inc XFOR

Glenn Schulman — Investor Relations or Call Moderator

Paula Ragan — Chief Executive Officer

Adam Mostafa — Chief Financial Officer

−1.0%1d on move date−0.8% vs SPY3d+18.1%5d+7.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XFOR calls or request research access.

More XFOR calls Browse calls Request research access